On January 30, 2023, Apexigen, Inc. closed the transaction. The company issued 1,995,708 common shares at an issue price of $1.4 per share for aggregate gross proceeds of approximately $2,793,991.2. The transaction included participation from 13 investors. The company paid finder's fee of $45,000 for the transaction.
1st Jan change | Capi. | |
---|---|---|
+15.82% | 122B | |
+20.35% | 114B | |
+17.87% | 25.71B | |
-25.31% | 19.02B | |
-20.51% | 15.83B | |
-19.67% | 15.32B | |
-46.87% | 14.88B | |
+62.55% | 14.82B | |
+6.34% | 14.1B |